Citius Pharms Drug Patent Portfolio
Citius Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Citius Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8440170 | Orally disintegrating tablets with speckled appearance | 14 Mar, 2029 | Active |
| US6149938 | Process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets and compositions obtained thereby | 23 Jul, 2018 | Expired |
Latest Legal Activities on Citius Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Citius Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 09 Nov, 2020 | US8440170 |
| Review Certificate Mailed | 16 Feb, 2018 | US8440170 |
| Review Certificate | 22 Dec, 2017 | US8440170 |
| Termination or Final Written Decision | 11 Oct, 2016 | US8440170 |
|
Request for Trial Granted
Critical
| 20 May, 2016 | US8440170 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 07 Dec, 2015 | US8440170 |
| Petition Requesting Trial | 24 Nov, 2015 | US8440170 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 14 May, 2013 | US8440170 |
|
Recordation of Patent Grant Mailed
Critical
| 14 May, 2013 | US8440170 |
|
Email Notification
Critical
| 25 Apr, 2013 | US8440170 |
|
Issue Notification Mailed
Critical
| 24 Apr, 2013 | US8440170 |
| Dispatch to FDC | 18 Apr, 2013 | US8440170 |
|
Application Is Considered Ready for Issue
Critical
| 16 Apr, 2013 | US8440170 |
|
Issue Fee Payment Verified
Critical
| 15 Apr, 2013 | US8440170 |
|
Issue Fee Payment Received
Critical
| 15 Apr, 2013 | US8440170 |
Citius Pharms's Drug Patent Litigations
Citius Pharms's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Nov 24, 2015, against patent number US8440170. The petitioner Spangenberg, Erich et al., challenged the validity of this patent, with ALPEX PHARMA as the respondent. Click below to track the latest information on how companies are challenging Citius Pharms's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US8440170 | November, 2015 |
Terminated
(11 Oct, 2016)
| ALPEX PHARMA | Spangenberg, Erich et al. |
Citius Pharms's Family Patents
Citius Pharms Drug List
Given below is the complete list of Citius Pharms's drugs and the patents protecting them.
1. Suprenza
Suprenza is protected by 2 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8440170 | Orally disintegrating tablets with speckled appearance |
14 Mar, 2029
(4 years from now)
| Active |
| US6149938 | Process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets and compositions obtained thereby |
23 Jul, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Suprenza's drug page